SCHEMBL206604

SCHEMBL206604

CC(C)COc1ccc(Nc2nc(-c3ccc4c(c3)NCCO4)cs2)cc1C(F)(F)F

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SYK P43405 1/20 0.45
ALDH1A1 P00352 9/20 0.44
MAPT P10636 9/20 0.44
MEN1 O00255 7/20 0.44
KMT2A Q03164 7/20 0.44
SMN1; SMN2 Q16637 6/20 0.44
RAB9A P51151 4/20 0.44
NPC1 O15118 3/20 0.44
TSHR P16473 1/20 0.44
HSD17B10 Q99714 1/20 0.44
GAA P10253 3/20 0.43
HTT P42858 3/20 0.43
MAPK1 P28482 1/20 0.43
CASP3 P42574 1/20 0.42
SENP8 Q96LD8 1/20 0.42
SENP7 Q9BQF6 1/20 0.42
SENP6 Q9GZR1 1/20 0.42
ALOX5 P09917 3/20 0.42
LMNA P02545 3/20 0.41
PTGS2 P35354 4/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL206194 0.88 SYK (0.46) SYKALDH1A1MAPTMEN1KMT2A
SCHEMBL2696390 0.86 ALDH1A1 (0.62) SYKALDH1A1MAPTMEN1KMT2A
SCHEMBL207924 0.83 ALDH1A1 (0.45) SYKALDH1A1MAPTMEN1KMT2A
SCHEMBL250087 0.81 ALOX5 (0.49) MAPTMEN1KMT2ASMN1; SMN2RAB9A
SCHEMBL204553 0.79 PTGS2 (0.57) ALDH1A1MAPTMEN1KMT2ASMN1; SMN2
SCHEMBL206879 0.78 MEN1 (0.56) ALDH1A1MAPTMEN1KMT2ASMN1; SMN2
SCHEMBL205627 0.76 PRMT5 (0.51) MAPTMEN1KMT2AGAAHTT
SCHEMBL2698212 0.75 ALDH1A1 (0.61) SYKALDH1A1MAPTMEN1KMT2A
SCHEMBL204308 0.74 ALDH1A1 (0.60) SYKALDH1A1MAPTMEN1KMT2A
SCHEMBL2694863 0.74 ALDH1A1 (0.59) SYKALDH1A1MAPTMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8088806-B2 Thiazole compounds and methods of use ACHILLION PHARMACEUTICALS, INC. (US) 2012-01-03 US disclosed
US-20070004711-A1 Thiazole compounds and methods of use ACHILLION PHARMACEUTICALS, INC. 2007-01-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070004711-A1 Thiazole compounds and methods of use PIGS, CPT1A, SLC10A1 SYK 3675/4885ALDH1A1 109/4885MAPT 2207/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.